Turkey

Turkey Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 279 adverse event reports for Turkey, distributed across 4 distinct breeds currently tracked in the system. Of those reports, 200 involved a death outcome — producing a 7170.0% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Turkey are Death (142 reports), Recumbency (59 reports), Increased mortality rate (44 reports), Lateral recumbency (35 reports), with Death leading the reaction traffic at 142 submissions. On the product side, Monensin Sodium is the single most-referenced drug with 189 reports, followed by Monensin (26), Lasalocid Sodium (10), Fenbendazol Powder Mix (9). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species — a useful starting point when comparing Turkey reporting patterns against other companion animals in the dataset.

Of the 325 Turkey reports with a coded outcome, Died accounts for the largest share at 59.7%. Annual submission volume spans 2,010 to 2,025 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 4 tracked turkey breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling — causation requires clinical investigation beyond what these aggregates can provide.